iwAL 2022 Session IV: The evolving treatment landscape in ALL and the growing role of immunotherapies episode artwork

EPISODE · Nov 22, 2022 · 16 MIN

iwAL 2022 Session IV: The evolving treatment landscape in ALL and the growing role of immunotherapies

from VJHemOnc Podcast · host VJHemOnc

The 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the field as they discussed several topics. In this podcast series, you will hear the latest updates in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and gain an insight into the sessions that took place at this year’s meeting. In this podcast, you will hear from Bijal Shah, MD, H. Lee Moffitt Cancer Center, Tampa, FL, Sabina Chiaretti, MD, PhD, Sapienza University of Rome, Rome, Italy, Elias Jabbour, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, and Nicolas Boissel, MD, PhD, Saint-Louis Hospital, Paris, France, who discuss the evolving treatment landscape in ALL, debating the role of immunotherapies, including antibody-drug conjugates (ADCs) and CAR-T cells.

Episode metadata supplied by the publisher feed · Published Nov 22, 2022

Embed this episode

NOW PLAYING

iwAL 2022 Session IV: The evolving treatment landscape in ALL and the growing role of immunotherapies

0:00 16:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of VJHemOnc Podcast?

This episode is 16 minutes long.

When was this VJHemOnc Podcast episode published?

This episode was published on November 22, 2022.

Can I download this VJHemOnc Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!